Reports
Sale
Global Aortic Stent Graft Market Size, Growth, Analysis: By Product: Abdominal Aortic Stent Graft, Thoracic Aortic Stent Graft; By End User: Hospitals, Ambulatory Surgical Centers, Others; Regional Analysis; Market Dynamics: Market Drivers and Constraints, SWOT Analysis, Porter’s Five Forces Model; Supplier Landscape; 2024-2032
Global Aortic Stent Graft Market Outlook
The global aortic stent graft market size was valued at USD 3.1 billion in 2023, driven by technological advancements in stent graft material and design across the globe. The market is expected to grow at a CAGR of 5.8% during the forecast period of 2024-2032, with the values likely to rise from USD 3.3 billion in 2024 to USD 5.2 billion by 2032.
Global Aortic Stent Graft Market Overview
An aortic stent graft is a tube consisting of fabric supported by a stent (a metal mesh). This stent graft is commonly used to treat a weak spot in an artery known as an aneurysm by sealing the artery both above and below the aneurysm. Aortic stent grafts allow blood to pass through the aorta and prevent the rupture of the aneurysm. It is primarily used to treat abdominal aortic aneurysms (AAAs) and thoracic aortic aneurysms (TAAs).
One of the key factors driving the aortic stent graft market growth is the rising prevalence of aortic aneurysms, which is characterized by the ballooning and weakening of the largest blood vessel in the body. This increase in the patient population directly impacts the demand for aortic stent grafts in the market. In addition, the COVID-19 pandemic has also influenced the market landscape. In May 2023, a study revealed that abdominal aortic aneurysm patients with a history of COVID-19 infection are 9.7 times more susceptible to experiencing rapid growth of their aneurysms. As a result, the need for innovative aortic stent grafts to reinforce the aorta wall and prevent the weak area from rupturing has become critical.
Several key market players are actively engaged in research and development activities aimed at technological innovation in stent grafts. Moreover, they are significantly investing in off-the-shelf or custom-made stent graft systems to meet the growing demand for personalized treatment, which is expected to boost the aortic stent graft market share in the coming years. In January 2024 , Endospan Ltd., an Israel based company specializing in off-the-shelf endovascular repair of aortic arch disease shared 30-day results from TRIOMPHE investigational device exemption (IDE) study of its product Nexus aortic arch stent graft system at the annual meeting of the Society of Thoracic Surgeons.
The clinical study in the first 22 patients, evaluating the effectiveness and safety of Endospan’s endovascular Nexus device in treating thoracic aortic lesions, revealed positive results with low mortality rate, no paraplegia, disabling strokes, or renal failure. Additionally, the data reported short intensive care units and hospital lengths of stay of the patients, indicating the efficacy of Nexus as a minimally invasive solution for aortic repair. While the product is available for investigational use in the United States, it is already approved in Europe. The rising accessibility and adoption of such innovative devices in the healthcare sector are likely to augment the market value in the forecast period.
Global Aortic Stent Graft Market Trends
| Key Trends | Impact |
| Technological Advancements | One of the significant market trends is the continuous innovation in stent graft materials and design has significantly improved the durability and flexibility of aortic stent grafts. These advancements have allowed the treatment of patients with challenging access to anatomy and reduced procedural complications. Additionally, improvements in imaging technologies and computational modeling result in better patient outcomes and reduced rates of endoleaks and graft migrations. |
| Growing Geriatric Population | The increase in the aging population, who are at a higher risk for aortic aneurysms is expected to drive the aortic stent graft market demand. This trend leads to a higher prevalence of cardiovascular diseases, including abdominal and thoracic aortic aneurysms. The growing elderly population size is a critical factor in the rising demand for stent grafts, fuelling innovation and supply to meet healthcare needs. |
| Rising Demand for Minimally Invasive Procedures | The rising patient’s inclination towards minimally invasive surgeries is due to their benefits, such as reduced recovery times and fewer complications. This trend significantly impacts the aortic stent graft market by increasing the demand for endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR) procedures over traditional open surgeries. This propels the demand for stent grafts as they are essential components of these minimally invasive treatments. |
| Increased Focus on Customization | The market is witnessing an increased focus on the customization of aortic stent grafts to align with the patient’s anatomy and disease specifics. Custom-made or off-the-shelf modular stent graft systems provide a more precise fit, reducing the risk of endoleaks significantly. This growing interest in personalized medicine in the vascular domain enhances the procedural success rate and patient satisfaction, accelerating market growth. |
Global Aortic Stent Graft Market Segmentation
Market Breakup by Product
- Abdominal Aortic Stent Graft
- Thoracic Aortic Stent Graft
By product, the market includes abdominal aortic stent grafts and thoracic aortic stent grafts. Abdominal aortic stent grafts are primarily used for abdominal aortic aneurysms (AAAs) whereas thoracic aortic stent grafts are used in the treatment of aneurysms and tears in the thoracic aorta, which is located in the chest.
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centers
- Others
In terms of end-users, the aortic stent graft market share includes hospitals, ambulatory surgical centers, and other healthcare facilities where patients undergo interventional procedures for aortic conditions.
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Based on region, the market report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America holds a significant share of the market which can be attributed to the evolving regulatory policies, the growing inclination of patients towards minimally invasive procedures, and the rising demand for customized aortic stent grafts.
Global Aortic Stent Graft Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Cook Group Incorporated
- W. L. Gore & Associates, Inc.
- Medtronic
- Terumo Corporation
- Cordis
- Artivion, Inc.
- Endologix LLC
- Lombard Medical
- SB-KAWASUMI LABORATORIES, INC.
- Endospan
- LifeTech Scientific Corporation
- Shanghai MicroPort Medical (Group) Co. Ltd.
- Cardinal Health
- Becton, Dickinson and Company
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Key Queries Solved in the Global Aortic Stent Graft Market Report
- What is the outlook for the aortic stent graft market in terms of growth, emerging trends, and market landscape?
- What will be the effect of each driver, challenge, and opportunity on the market?
- Which regional market is poised to lead the market share in the forecast period?
- Which regional market is expected to experience expedited growth during the forecast period?
- What types of aortic stent grafts are contributing significantly to the aortic stent graft market size?
- What type of product in the market is expected to dominate the respective market segment?
- Which end user in the market is expected to contribute significantly to the market growth?
- What are the technological advancements expected to boost the market value during the forecast period?
- How does the regulatory landscape impact the market size?
- How are patient preferences influencing market demand?
- Which segment has the highest impact on the market size?
- How are partnerships, collaborations, and mergers & acquisitions shaping the market dynamics?
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Aortic Stent Graft Market Overview
3.1 Global Aortic Stent Graft Market Historical Value (2017-2023)
3.2 Global Aortic Stent Graft Market Forecast Value (2024-2032)
4 Global Aortic Stent Graft Market Landscape*
4.1 Global Aortic Stent Graft Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Aortic Stent Graft Market: Product Landscape
4.2.1 Analysis by Product
5 Global Aortic Stent Graft Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Aortic Stent Graft Market Segmentation (2017-2032)
6.1 Global Aortic Stent Graft Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Abdominal Aortic Stent Graft
6.1.3 Thoracic Aortic Stent Graft
6.2 Global Aortic Stent Graft Market (2017-2032) by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Ambulatory Surgical Centers
6.2.4 Others
6.3 Global Aortic Stent Graft Market (2017-2032) by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Aortic Stent Graft Market (2017-2032)
7.1 North America Aortic Stent Graft Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Abdominal Aortic Stent Graft
7.1.3 Thoracic Aortic Stent Graft
7.2 North America Aortic Stent Graft Market (2017-2032) by Country
7.2.1 United States of America
7.2.2 Canada
8 Europe Aortic Stent Graft Market (2017-2032)
8.1 Europe Aortic Stent Graft Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Abdominal Aortic Stent Graft
8.1.3 Thoracic Aortic Stent Graft
8.2 Europe Aortic Stent Graft Market (2017-2032) by Country
8.2.1 United Kingdom
8.2.2 Germany
8.2.3 France
8.2.4 Italy
8.2.5 Others
9 Asia Pacific Aortic Stent Graft Market (2017-2032)
9.1 Asia Pacific Aortic Stent Graft Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Abdominal Aortic Stent Graft
9.1.3 Thoracic Aortic Stent Graft
9.2 Asia Pacific Aortic Stent Graft Market (2017-2032) by Country
9.2.1 China
9.2.2 Japan
9.2.3 India
9.2.4 ASEAN
9.2.5 Australia
9.2.6 Others
10 Latin America Aortic Stent Graft Market (2017-2032)
10.1 Latin America Aortic Stent Graft Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Abdominal Aortic Stent Graft
10.1.3 Thoracic Aortic Stent Graft
10.2 Latin America Aortic Stent Graft Market (2017-2032) by Country
10.2.1 Brazil
10.2.2 Argentina
10.2.3 Mexico
10.2.4 Others
11 Middle East and Africa Aortic Stent Graft Market (2017-2032)
11.1 Middle East and Africa Aortic Stent Graft Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Abdominal Aortic Stent Graft
11.1.3 Thoracic Aortic Stent Graft
11.2 Middle East and Africa Aortic Stent Graft Market (2017-2032) by Country
11.2.1 Saudi Arabia
11.2.2 United Arab Emirates
11.2.3 Nigeria
11.2.4 South Africa
11.2.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Cook Group Incorporated
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 W. L. Gore & Associates, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Medtronic
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Terumo Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Cordis
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Artivion, Inc
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Endologix LLC
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Lombard Medical
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 SB-KAWASUMI LABORATORIES, INC.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Endospan
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 LifeTech Scientific Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Shanghai MicroPort Medical (Group) Co. Ltd.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Cardinal Health
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Becton, Dickinson and Company
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Aortic Stent Graft Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 3.1 billion in 2023 driven by technological advancements in stent graft material and design across the globe.
The market is anticipated to grow at a CAGR of 5.8% during the forecast period of 2024-2032, likely to reach a market value of USD 5.2 billion by 2032.
The market demand is driven by rise in the aging population, who are at a higher risk for aortic aneurysms along with increasing healthcare expenditures.
One of the significant trends in the market is the development of minimally invasive aortic stent grafts by the leading market players. In January 2024 , Endospan Ltd specializing in off-the-shelf endovascular repair of aortic arch disease shared 30-day results from TRIOMPHE investigational device exemption (IDE) study of its product Nexus aortic arch stent graft system at the annual meeting of the Society of Thoracic Surgeons.
On the basis of product, the market includes into abdominal aortic stent grafts and thoracic aortic stent grafts.
Major end users of the market include hospitals, and ambulatory surgical centers, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are Cook Group Incorporated, W. L. Gore & Associates, Inc., Medtronic, Terumo Corporation, Cordis, Artivion, Inc, Endologix LLC, Lombard Medical, SB-KAWASUMI LABORATORIES, INC., Endospan, LifeTech Scientific Corporation, Shanghai MicroPort Medical (Group) Co. Ltd., Becton, Dickinson and Company, and Cardinal Health.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER